nasdaq:dxcm
|
42221
|
Sep 17th, 2023 12:00AM
|
Dexcom
|
114K
|
5809
|
Open
|
Medical Equipment Manufacturing
|
Sep 16th, 2023 10:55PM
|
Sep 16th, 2023 10:55PM
|
Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes. Since the company’s inception, Dexcom has focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering the community to take control of diabetes. Headquartered in San Diego, California, with additional offices in the U.S., Europe, and Asia Pacific, the company employs over 9,000 people globally.
|
Open
|
Continuous Glucose Monitoring, Medical Devices, Diabetes, Decision Support, Data, Mobile Software, and Sensors
|
Open
|
5375 Mira Sorrento Place
|
San Diego
|
California
|
US
|
92121
|
|
DexCom
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:dxcm
|
42221
|
Sep 16th, 2023 12:00AM
|
Dexcom
|
114K
|
5809
|
Open
|
Medical Equipment Manufacturing
|
Sep 15th, 2023 11:30PM
|
Sep 16th, 2023 01:33PM
|
Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes. Since the company’s inception, Dexcom has focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering the community to take control of diabetes. Headquartered in San Diego, California, with additional offices in the U.S., Europe, and Asia Pacific, the company employs over 9,000 people globally.
|
Open
|
Continuous Glucose Monitoring, Medical Devices, Diabetes, Decision Support, Data, Mobile Software, and Sensors
|
Open
|
5375 Mira Sorrento Place
|
San Diego
|
California
|
US
|
92121
|
|
DexCom
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:dxcm
|
42221
|
Sep 15th, 2023 12:00AM
|
Dexcom
|
114K
|
5794
|
Open
|
Medical Equipment Manufacturing
|
Sep 14th, 2023 11:28PM
|
Sep 15th, 2023 07:03PM
|
Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes. Since the company’s inception, Dexcom has focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering the community to take control of diabetes. Headquartered in San Diego, California, with additional offices in the U.S., Europe, and Asia Pacific, the company employs over 9,000 people globally.
|
Open
|
Continuous Glucose Monitoring, Medical Devices, Diabetes, Decision Support, Data, Mobile Software, and Sensors
|
Open
|
5375 Mira Sorrento Place
|
San Diego
|
California
|
US
|
92121
|
|
DexCom
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:dxcm
|
42221
|
Sep 14th, 2023 12:00AM
|
Dexcom
|
114K
|
5794
|
Open
|
Medical Equipment Manufacturing
|
Sep 13th, 2023 11:17PM
|
Sep 13th, 2023 11:17PM
|
Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes. Since the company’s inception, Dexcom has focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering the community to take control of diabetes. Headquartered in San Diego, California, with additional offices in the U.S., Europe, and Asia Pacific, the company employs over 8,000 people globally.
|
Open
|
Continuous Glucose Monitoring, Medical Devices, Diabetes, Decision Support, Data, Mobile Software, and Sensors
|
Open
|
5375 Mira Sorrento Place
|
San Diego
|
California
|
US
|
92121
|
|
DexCom
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:dxcm
|
42221
|
Sep 13th, 2023 12:00AM
|
Dexcom
|
114K
|
5794
|
Open
|
Medical Equipment Manufacturing
|
Sep 12th, 2023 11:34PM
|
Sep 12th, 2023 11:34PM
|
Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes. Since the company’s inception, Dexcom has focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering the community to take control of diabetes. Headquartered in San Diego, California, with additional offices in the U.S., Europe, and Asia Pacific, the company employs over 8,000 people globally.
|
Open
|
Continuous Glucose Monitoring, Medical Devices, Diabetes, Decision Support, Data, Mobile Software, and Sensors
|
Open
|
5375 Mira Sorrento Place
|
San Diego
|
California
|
US
|
92121
|
|
DexCom
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:dxcm
|
42221
|
Sep 12th, 2023 12:00AM
|
Dexcom
|
114K
|
5794
|
Open
|
Medical Equipment Manufacturing
|
Sep 11th, 2023 11:27PM
|
Sep 12th, 2023 06:31PM
|
Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes. Since the company’s inception, Dexcom has focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering the community to take control of diabetes. Headquartered in San Diego, California, with additional offices in the U.S., Europe, and Asia Pacific, the company employs over 8,000 people globally.
|
Open
|
Continuous Glucose Monitoring, Medical Devices, Diabetes, Decision Support, Data, Mobile Software, and Sensors
|
Open
|
5375 Mira Sorrento Place
|
San Diego
|
California
|
US
|
92121
|
|
DexCom
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:dxcm
|
42221
|
Sep 11th, 2023 12:00AM
|
Dexcom
|
114K
|
5792
|
Open
|
Medical Equipment Manufacturing
|
Sep 10th, 2023 11:07PM
|
Sep 11th, 2023 04:19PM
|
Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes. Since the company’s inception, Dexcom has focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering the community to take control of diabetes. Headquartered in San Diego, California, with additional offices in the U.S., Europe, and Asia Pacific, the company employs over 8,000 people globally.
|
Open
|
Continuous Glucose Monitoring, Medical Devices, Diabetes, Decision Support, Data, Mobile Software, and Sensors
|
Open
|
5375 Mira Sorrento Place
|
San Diego
|
California
|
US
|
92121
|
|
DexCom
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:dxcm
|
42221
|
Sep 10th, 2023 12:00AM
|
Dexcom
|
114K
|
5787
|
Open
|
Medical Equipment Manufacturing
|
Sep 9th, 2023 11:10PM
|
Sep 9th, 2023 11:10PM
|
Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes. Since the company’s inception, Dexcom has focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering the community to take control of diabetes. Headquartered in San Diego, California, with additional offices in the U.S., Europe, and Asia Pacific, the company employs over 8,000 people globally.
|
Open
|
Continuous Glucose Monitoring, Medical Devices, Diabetes, Decision Support, Data, Mobile Software, and Sensors
|
Open
|
5375 Mira Sorrento Place
|
San Diego
|
California
|
US
|
92121
|
|
DexCom
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:dxcm
|
42221
|
Sep 9th, 2023 12:00AM
|
Dexcom
|
113K
|
5787
|
Open
|
Medical Equipment Manufacturing
|
Sep 8th, 2023 10:53PM
|
Sep 9th, 2023 02:36PM
|
Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes. Since the company’s inception, Dexcom has focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering the community to take control of diabetes. Headquartered in San Diego, California, with additional offices in the U.S., Europe, and Asia Pacific, the company employs over 8,000 people globally.
|
Open
|
Continuous Glucose Monitoring, Medical Devices, Diabetes, Decision Support, Data, Mobile Software, and Sensors
|
Open
|
5375 Mira Sorrento Place
|
San Diego
|
California
|
US
|
92121
|
|
DexCom
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:dxcm
|
42221
|
Sep 8th, 2023 12:00AM
|
Dexcom
|
113K
|
5774
|
Open
|
Medical Equipment Manufacturing
|
Sep 7th, 2023 11:09PM
|
Sep 7th, 2023 11:09PM
|
Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes. Since the company’s inception, Dexcom has focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering the community to take control of diabetes. Headquartered in San Diego, California, with additional offices in the U.S., Europe, and Asia Pacific, the company employs over 8,000 people globally.
|
Open
|
Continuous Glucose Monitoring, Medical Devices, Diabetes, Decision Support, Data, Mobile Software, and Sensors
|
Open
|
5375 Mira Sorrento Place
|
San Diego
|
California
|
US
|
92121
|
|
DexCom
|
Health Care
|
Health Care Equipment & Services
|